“novartis” Archives

in
Entry Author Date Location
Propeller, Express Scripts Partner to Monitor Asthma, COPD Patients 11/16/17 Wisconsin
At Seattle Children’s, Another Piece of Ambitious CAR-T Plan in Place 11/16/17 Seattle
With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer 11/14/17 Boston
Juno Dissects ROCKET Deaths, Will Aim Better CAR-T at Leukemia 11/10/17 Seattle
FDA Lifts Hold on Cellectis’s “Off the Shelf” CAR-T, With Caveats 11/07/17 New York
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOs & More 11/03/17 National
ASH Sneak Peeks: Novartis, Juno Update CAR-T Lymphoma Competition 11/01/17 National
Eli Lilly Drug Fails in Lung Cancer, Stalling Oncology Strategy 10/10/17 Indiana
Ag Secretary Perdue Hears Startups Call for More Research Support 10/06/17 Raleigh Durham
Bio Roundup: RNAi’s Big Day, CAR-T For Kids, Drugs From Fungi & More 09/22/17 National
Alnylam Data Puts a Nobel Discovery One Step Closer to Approved Drug 09/20/17 Boston
On CAR-T’s Edge, Seattle Researchers Plot to Bypass Novartis Therapy 09/19/17 National
After Biogen Deal Fizzles, Rodin Bags $27M And Heads To First Trial 09/18/17 Boston
Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More 09/08/17 National
As Key Data Loom, Nobel Winner Mello Reflects on RNAi “Sci-Fi” Story 09/06/17 Boston
Patient Death Triggers FDA Hold For Cellectis’s “Off the Shelf” CAR-T 09/05/17 New York
Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More 09/01/17 National
Novartis: CAR-T Results In One Month, Or No Charge. Why One Month? 08/31/17 National
Novartis Wins Historic FDA Nod, Prices CAR-T For Leukemia at $475,000 08/30/17 National
Jazz Pharma, ImmunoGen Strike Up Drug Pact in Leukemia and More 08/29/17 Boston
Gilead Makes Long-Awaited Splash With $12B Bet on Kite, Cell Therapy 08/28/17 San Francisco
Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand 08/25/17 National
Breaking Barriers & Building Bridges: Xconomy’s Diversity Award Finalists 08/23/17 Boston
Ophthotech’s Final Try at Combo Eye Drug Comes up Short 08/14/17 New York
IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout 08/03/17 Boston
With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug 08/01/17 Boston
Homology Med Bags $83.5M More, Fueling Push For Gene Editing Twist 08/01/17 Boston
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
Akcea Slashes IPO Price Ahead of Filing for Rare Disease Drug 07/14/17 Boston
Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More 07/14/17 National
Page 1 of 20 next page »